Bioinformatics Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

DNA bioinformatics

A

Use of computational tools to analyse large amounts of data, such as DNA and amino acid sequences
-There are billions of base pairs and so we need computer to help analyse these bases and compare to other populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is data generated

A

DNA sequencing such as Sanger and NGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Genetic variation

A

-Explains differences in phenotype from a genetic perspective
-It accounts for some of the differences amongst us. As such our genotype affects our phenotype. eg height and eye colour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do changes to DNA occur

A

-SNPs, INDELS (Insertion/deletion)
-Rearranges-large often chromosomal level changes
-Most changes occur in non-coding sequences (introns and intergenic)
-To identify where these are in the genome, DNA changes are given ID numbers that start with rs
-Some changes can affect our health such as disease susceptibility and response to medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacogenetics

A

The relationship between genetic variation and response to medicine
-It is how a specific gene responds to a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacokinetics

A

The way a drug is absrobed, distributed, metabolised and eliminated (ADME)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacodynamics

A

Biochemical and physiological effects of a drug
-When a drug interacts with a target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effects of pharmacogenetic variation

A

-Response to a drug
-Adverse drug reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacogenomics

A

How an individuals entire genetic makeup of a specific population responds to a drug
(How a pop responds to a drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

E. Genetic variation affects pharmacokinetic profile of metabolism

A

-If a drug is metabolised too quickly, then it might not be as effective as it is eliminated before it can be effective. Conversely, if a drug is metabolised too slowly, it may reach excessive levels in the body and cause adverse effects
-When a drug is metabolised its active form becomes inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Genetic variation effects on Distribution

A

If a drug requires transport into the cell and a variant prevents adequate transport and therefore uptake into the cell, the drug will not reach its intended target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

genetic variation can alter the pharmacodynamic effects of a drug

A

If a drug binds to a specific protein to have an effect, a change in a single base pair could change an amino acid in the protein. This could modify the way in which (and even prevent) a drug binds to the protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Warfarin

A

Blood thinner: used to treat high blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is CYP2C9

A

-It is a detoxifiatory enzyme
-It is involved in metabolising warfarin: variations like CYP2C9 and CYP2C93 cause it to be metabolised slower
-They respond first to toxic chemicals
-CYP refers to the cytochrome P450 family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is VKORC1

A

It is involved in metabolism of vitamin K and so is engaged in thickening of blood in clotting
-Warfarin is used to block the action of genes to thin blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the relationship between CYP2C9 (coding), VKORC1 and warfarin

A

CYP2C9 metabolises the drug
-VKORC1 thickens the blood
-Both affect the dose needed for warfarin

17
Q

How can genetic variation in CYP2C9 (coding) and VKORC1 (promoter) impact warfarin treatment

A

CYP2C9 variations can lead to drug not being metabolised properly leading to too much drug in the system
VKORC1 variations can cause blood to be thicker than normal, requiring high amounts of the drug to be effective. Changes in promoter region -1639G/A
-Results in certain transcription factors being unable to bind which results in lower expression